BioSpace Layoff Tracker 2022: Cyclerion, OncoSec Implement Restructuring Initiatives

As the economy ebbs and flows, pharma and biotech companies alike are feeling the pressure to cut costs. From rapid inflation to the ever-changing regulatory landscape, many are looking for ways to reduce their burn rate.

One way to do this is by reducing staff, and so far, the layoff trend has continued into the second half of 2022. For that and more, continue reading.